Management Team

InSphero’s leadership team combines many years’ scientific and commercial experience in 3D microtissue engineering, cell based assays, laboratory automation, and industry-scale production and quality assurance. It is complemented by the strategic management expertise of our Board of Directors and Strategic Advisory Board members.


 MG 1290

Dr. Jan Lichtenberg
Chief Executive Officer, Co-Founder & Member of the Management Team

Engineer and expert in laboratory automation with 20 years of experience in high-tech startups from chemical processing to medical devices.


 MG 1427

Dr. Frank Junker
Chief Business Officer & Member of the Management Team

Life-Science professional with more than 15 years industry experience, where he held various positions in sales & marketing, product management and business development. His experience ranges from bioinformatics, in vitro diagnostics, and cell-culture in mid-sized and as well as large corporations. Frank holds a PhD in molecular microbiology from the ETH Zurich, and an MBA in Economics from The Open University.



Wolfgang Moritz, PhD
Head of External Development Collaborations & IP, Co-Founder & Member of the Managment Team

Expert in production and assay methods for microtissues using laboratory-scale approaches, valuable background in clinical applications of microtissues. Manages external collaborations and supports development of new platform technologies.


 MG 1461

Oliver Krähenbühl
MBA, Chief Financial Officer & Member of the Management Team

Qualified Accountant with over 25 years of experience at rapidly growing companies in the technology field. Expert in corporate finance including funding, corporate transactions and M&A. Experienced in systems integration and process reengineering.


PatrickGuye MG 0712

Dr. Patrick Guye
Chief Scientific Officer & Member of the Management Team

Extensive experience in life sciences, engineering, business innovation & development, operations and new ventures consulting. Held leadership positions in industry (Sanofi) and academia (Massachusetts Institute of Technology, Princeton University) with focus on cell therapy, 3D cellular models/organoids, synthetic biology, human stem cells, biologics and small molecules development, and precision genomic engineering. Patrick earned his PhD in Molecular Infection Biology from the University of Basel.



Randy Strube, PhD
Director of Global Marketing InSphero Inc. USA & Member of the Management Team

Trained in cancer biology with emphasis in gene therapy and antibody engineering, he possesses >12 years of professional life sciences marketing and management experience. A skilled technical writer with a proven track record of communicating product value, building brand strength, and growing product sales within industry and academic segments. Randy holds a PhD in Cancer Biology from Wake Forest University.



David Fluri, PhD
Head of Operations & Member of the Management Team

Experienced Scientist and member of the InSphero team since 2012. He has long standing industry experience in advanced in vitro model development, standardization and automation. David holds a PhD in molecular biotechnology from ETH Zurich.


 MG 1373

Marion Bavand, PhD
Head of Quality Assurance & Member of the Management Team

A seasoned Quality Assurance and Regulatory Affairs professional with 20+ years of experience in pre-market and post-market product development of life science- & biotech products and medical devices, including medical device vigilance and postmarket surveillance. Hands-on experience in establishing Quality Systems supporting pre-clinical and clinical product development and product release to market.


 MG 1209

Katrin Roduner, PhD
Head of Human Resources & Member of the Management Team

HR professional with over 9 years of experience in talent management, learning & development, operational HR, assessment, Management Development, coaching and training.


 MG 1004

Simon Messner, PhD
Head of Product Management

Trained biochemist and molecular biologist with extensive experience in product development, characterization and application of 3D microtissues.


Board of Directors



Dr. Jens M. Kelm, Chief Technology Officer InSphero AG & Member of the Management Team

Dr. Jan Lichtenberg, Chief Executive Officer InSphero AG & Member of the Management Team

Thomas Pfisterer, Wild Group Management AG

Dr. Jürg Gysi, President of the Board, Switzerland

Former CEO, Promega AG Switzerland. Molecular Biologist with more than 30 years of experience in sales, marketing and management in the biotech industry in Switzerland, Germany and the US.

Beat Schillig, Founder and President IFJ Institute for Young Entrepreneurs

Serial Entrepreneur and Business Angel.

Dr. Thomas Rinderknecht, Senior Partner at Badertscher Rechtsanwälte

Has served on the boards of directors of several biotech, pharma and medtech companies, including amongst others Basilea, Speedel AG, Basel, Glycart Biotechnology AG and Ganymed Pharmaceuticals AG. Ph.D. in law from the University of Zurich, admitted to the Bar in Zurich.

Anna Evodokimova, VC Investment Director at Millhouse LLC


Strategic Advisory Board


Professor Gordon McVie

Professor Gordon McVie (born 13 January 1945) is an international authority on the treatment and research of cancer. Along with Umberto Veronesi he is the founding editor of ecancermedicalscience, an open access cancer journal from the European Institute of Oncology in Milan.

 Dr. Igor Koman

Dr. Igor Koman is the Director of Ariel University's Institute for Personalized Medicine. Dr. Komen graduated from the Russian Medical University and holds a PhD and DSc in clinical pharmacology.


Charles Qualls, DVM, PhD, DACVP

Dr. Qualls is a toxicology expert who retired as Executive Director of Investigative Toxicology and Pathology at Amgen Inc. Before working at Amgen, he served as Director of Molecular and Ultrastructural Pathology at GlaxoSmithKline. Dr. Qualls had a distinguished career over two decades in academia prior to moving into the pharmaceutical industry. 


Dr. Jean Krutman

Professor Krutman is currently the scientific director of the Leibniz Research Institute for Environmental Medicine, Düsseldorf Germany.


Dr. Med. Sci. Frédéric Lévy

Head of Research & Evaluation at Debiopharm International SA and Associate Professor at the Faculty of Biology and Medicine, University of Lausanne with more than 50 peer-reviewed scientific publications. Dr Med Sc, Biochemistry/Immunology and Postdoc at California Institute of Technology

Company video